Navigation Links
Medtronic, Lilly Diabetes Join Together as First Ever National Presenting Sponsors of the JDRF Walk To Cure Diabetes
Date:11/1/2013

MINNEAPOLIS and NEW YORK and INDIANAPOLIS, Nov. 1, 2013 /PRNewswire/ --

News Highlights:

  • Medtronic and Lilly Diabetes become first ever national presenting sponsors of the #JDRF Walk to Cure #Diabetes
  • Medtronic, Lilly Diabetes help fund more than $500K for #T1D research through #JDRF Walk to Cure #Diabetes national sponsorship  
  • Medtronic, Lilly Diabetes' #JDRF Walk to Cure #Diabetes national sponsorship announcement kicks off #T1Day and #NDAM on Nov. 1
  • Medtronic and Lilly Diabetes announced today that they will serve as national presenting sponsors of this season's JDRF Walk to Cure Diabetes. As the national presenting sponsors, Medtronic and Lilly will host educational booths at select local events and will work with their employees to form Walk teams at each location. The sponsorship, a first for JDRF and the Medtronic-Lilly Alliance, will help JDRF fund more than half a million dollars for type 1 diabetes (T1D) research.

    The announcement comes on T1Day, an annual observance JDRF established to help educate the public about T1D, including the signs and symptoms, life with the disease, differences between type 1 and type 2 diabetes, and research progress. November 1 also officially kicks off National Diabetes Awareness Month (NDAM) in the United States. 

    "The JDRF Walk to Cure Diabetes is about communities coming together to make a difference for people with type 1 diabetes," said Margo K. Lucero, JDRF's vice president of corporate development. "We are incredibly grateful to have Medtronic and Lilly, and their committed employees, on our team to help us make our 2014 season a huge success."

    Since 1992, the JDRF Walk to Cure Diabetes, the organization's flagship fundraising program, has raised more than $1 billion toward research to progressively remove the impact of T1D from people's lives until ther
    '/>"/>

    SOURCE Eli Lilly and Company; Medtronic
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Zacks.com featured expert Kevin Matras highlights: Core Laboratories NV, Invesco Ltd., Medtronic, Inc., Willbros Group Inc. and WuXi PharmaTech Inc.
    2. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    3. Lilly announces Tapiero retiring; Zulueta promoted to senior vice president and president of Emerging Markets
    4. Lilly Reports Third-Quarter 2013 Results
    5. FDA Grants Lillys Ramucirumab Priority Review as a Potential Single-Agent Treatment for Advanced Gastric Cancer
    6. Lilly Declares Fourth-Quarter 2013 Dividend
    7. Lilly Reintegration Scholarship Applications Available for 2014-2015 Academic Year
    8. Lilly to host investment community meeting at its Indianapolis headquarters on Thursday, October 3, 2013
    9. Data Presented at 49th EASD Annual Meeting Show Treatment with Lillys Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes
    10. Lilly Announces Second Positive Ramucirumab Phase III Gastric Cancer Study Meets Primary Endpoint; Phase III Lilly/TRIO Breast Cancer Study Misses Primary Endpoint
    11. Exosome Diagnostics Enters Collaboration Agreement with Lilly for Exosome Blood-Based Biomarker Discovery
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/28/2015)... May 28, 2015  Eli Lilly and Company (NYSE: ... announced cash tender offer for up to $1.6 billion aggregate ... Holders of notes who tendered, and did not validly ... New York City time, on May 27, 2015 ... by Lilly, are eligible to receive the total consideration. The ...
    (Date:5/28/2015)... NEW YORK , May 28, 2015 ... billions developing new drugs and tests, and ... for the instruments that can assist them. This ... research publisher. Kalorama Information said instruments such as ... can assist in the identification of drug ...
    (Date:5/28/2015)... , May 28, 2015 Henry ... largest provider of health care products and services ... today reminded its customers that the Henry Schein ... and veterinarians who experience operational, logistical or financial ... in the South Central region of the U.S. ...
    Breaking Medicine Technology:Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 2Henry Schein Disaster Relief Hotline Is Open To Support Customers Affected By Storms In South Central, U.S. 3
    ... Oct. 12 Actavis Group, the international ... approval from the US Food & Drug Administration to ... Merck,s Cozaar® in 25 mg, 50 mg and 100 ... Actavis R&D in Iceland. Losartan Potassium Tablets, ...
    ... OCEANSIDE, N.Y., Oct. 12 WPI Holdings d/b/a Woodbury ... Partners, LLC ("HealthEdge"), announced today that it has completed ... Based in Wilmington, North Carolina and founded in ... and equipment, primarily focused on urological catheters and sterile ...
    Cached Medicine Technology:Actavis Receives Approval of Losartan Potassium Tablets, USP in the U.S. 2WPI Holdings Acquires Wilmington Medical Supply Inc. 2
    (Date:5/29/2015)... 29, 2015 World Patent Marketing, a ... that it has signed a 10 year licensing agreement ... aims to let people learn about any topic and ... , "This is an exciting day for World Patent ... J. Cooper, CEO and Creative Director of World Patent ...
    (Date:5/29/2015)... 29, 2015 Mediaplanet has joined forces ... protection”. Skin Health is a cross-platform campaign with ... markets of New York, Los Angeles, and Chicago, the ... Its digital counterpart will reach a national audience through ... more the Skin Health campaign and Colorescience, click ...
    (Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... H1 2015” provides comprehensive information on the therapeutic ... different types of muscles in the body, leading ... strengthens R&D pipelines by identifying new targets and ... report on H1 2015 pipeline review of Axillary ...
    (Date:5/29/2015)... Designed with the versatile athlete in mind, ... all new, exclusive line of supplementation called The 24/7 ... and greatest, high impact, result driven ingredients that have ... 24/7 Series can be used by anyone from bodybuilders ... fitness enthusiasts. There are no stimulant based ingredients that ...
    (Date:5/29/2015)... 2015 The annual aesthetic meeting, put on ... held in Montreal from May 14-19th. This global event ... from around the world; dedicating itself exclusively to cosmetic medicine. ... renowned plastic surgeons to attend this year’s meeting. , ... Dr. Vitenas was given the honor of sitting at the ...
    Breaking Medicine News(10 mins):Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Muscle Spasm Therapeutic Development Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 2Health News:BPI Sports and Bodybuilding.com Partner Up to Bring an Innovative New Line of Supplements 3Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 2Health News:Dr. Paul Vitenas Presents at 2015 Aesthetic Meeting 3
    ... Corporation,(Nasdaq: DRRX ) announced today that James ... at the SIGnificant Investment Options,in Healthcare conference hosted ... at 2:45 p.m. EST. The conference is being ... York City., (Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ), ...
    ... but significant association , , FRIDAY, Feb. 28 (HealthDay News) ... and taking vitamin E may even heighten the risk, ... supplement-taking habits and lung cancer incidence of almost 78,000 ... period. , "Our study of supplemental multivitamins, vitamin C, ...
    ... Pitching ... Legend Tommy John, SARASOTA, Fla. ... and retail company focused on providing,hearing aids with state-of-the-art fidelity, price ... Square Mall,(Sarasota) and Gulf View Mall (Port Richey)., Years ago, ...
    ... Feb. 29 Landauer, Inc. (NYSE:,LDR) announced today that ... of $0.50 per share for the second quarter of ... 2008, to shareholders of record,on March 14, 2008., ... analytical services to determine,occupational and environmental radiation exposure. For ...
    ... Calif., Feb. 29 Genoptix, Inc.,(Nasdaq: GXDX ), ... stock being offered by certain existing stockholders to,the public ... will not,receive any proceeds from the sale. The offer ... offering is being made through an underwriting syndicate led ...
    ... Feb. 29 /Xinhua-PRNewswire-FirstCall/ -- Qiao Xing,Mobile Communication Co., Ltd. ... one of China,s leading domestic manufacturers of mobile,handsets through ... launch of its new C7000A cardiograph mobile handset., ... Cardiograph function -- Users will be able to perform ...
    Cached Medicine News:Health News:Vitamin E Supplements May Raise Lung Cancer Risk 2Health News:Vitamin E Supplements May Raise Lung Cancer Risk 3Health News:Zounds! - Sarasota and Port Richey 'Hear' New Retail Concept Coming 2Health News:Zounds! - Sarasota and Port Richey 'Hear' New Retail Concept Coming 3Health News:Genoptix Announces Pricing of Secondary Public Offering 2Health News:Qiao Xing Mobile's CECT Subsidiary Releases Newest Handset Model; C7000A Offers Cardiograph, 120 Days Ultra-Long Standby and 3.0'' LCD Screen 2Health News:Qiao Xing Mobile's CECT Subsidiary Releases Newest Handset Model; C7000A Offers Cardiograph, 120 Days Ultra-Long Standby and 3.0'' LCD Screen 3
    Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours...
    ... provide protection to the exposed airway of the ... making it ideal for active young children as ... heat and moisture recovery, it ensures patient comfort ... filters have ISO standard tapered ends to assure ...
    ... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
    Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
    Medicine Products: